COVID-19
Not recruitingStudy on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
Germany- Participants:18–64 years · 65+ years
- Substances:Abatacept
Rare diseases
Investigational molecules
Locations
Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
GermanyStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
GermanyStudy on Linaclotide for Treating Functional Constipation in Children Aged 6 Months to Less Than 2 Years
GermanyStudy of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer
GermanyStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
GermanyStudy on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression
GermanyStudy on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
GermanyStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs
GermanyStudy on the Safety and Effects of Garadacimab for Preventing Hereditary Angioedema in Children Aged 2 to 11
GermanyStudy on the Safety and Effectiveness of R2R01 and Terlipressin for Patients with Hepatorenal Syndrome and Acute Kidney Injury
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.